Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCD for Recurrent/Refractory Adult LCH
NCT04120519Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Oct 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in Langerhans cell histiocytosis (LCH), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
thalidomide
03
Conditions
Langerhans cell histiocytosis (LCH)
Beyond the preview
Go deeper on NCT04120519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04120519.